APT Pharmaceuticals, Inc.

HOME OUR TEAM NEWS PIPELINE CONTACT US



	PRESS RELEASES SEPTEMBER 30, 2008 APT Pharmaceuticals Secures $32 Million in Series B Financing DECEMBER 3, 2007 APT Pharmaceuticals Adds Paul Sekhri to Board of Directors NOVEMBER 19, 2007 APT Pharmaceuticals Expands Management Team OCTOBER 4, 2007 APT Pharmaceuticals Closes New $22 Million Funding Round JUNE 5, 2007 APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection SEPTEMBER 6, 2006 Former Chiron Executive Joins APT Pharmaceuticals as CEO MARCH 21, 2006 APT Pharmaceuticals Adds Vivo Ventures in Final Close of $9 Million First Round


	MEDIA COVERAGE PALO ALTO /KGO ABC7 NEWS – JULY 8, 2008 APT supports Team Northern California at USA Transplant Games START-UP MAGAZINE – MAY 2008 APT profiled in Start-Up Magazine SILICON VALLEY / SAN JOSE BUSINESS JOURNAL– NOVEMBER 2, 2007 APT Moves Are Closely Followed DOWJONES VENTUREWIRE– OCTOBER 5, 2007 Specialty Drug Co. APT Pharma Breathes In $22M BIOWORLD TODAY– OCTOBER 5, 2007 APT Targeting Lung Transplant, Disease With $22M Financing SAN FRANCISCO BUSINESS TIMES – JUNE 15, 2007 Chiron Refugees Adopt 'Orphans' from Novartis

START-UP MAGAZINE – MAY, 2008

APT profiled in Start-Up Magazine